| [1] |
ZHANG Shiyi, SUN Jiamin, ZHONG Jianhong, WANG Qiuyan, TAO Yuting.
Clinical significance of YAP signaling activation in extracellular matrix remodeling in hepatocellular carcinoma and its molecular mechanisms
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 30-39.
|
| [2] |
LI Meng, LI Pingchuan, LIU Xiaoqiang, YANG Huawei.
Effects of MCM5 knockdown on proliferation,migration and apoptosis of breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 40-47.
|
| [3] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
| [4] |
WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei.
Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
|
| [5] |
CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng.
Trend of mortality and disease burden of gastric cancer in China,2004—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
|
| [6] |
WANG Huimin, ZHAO Dongming, LI Xianfeng.
Research progress on multifunctional nano-drug delivery system in the treatment of liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 128-132.
|
| [7] |
LIN Leipo, HUANG Zhihao, XIANG Bangde, MA Liang, LI Lequn, ZHONG Jianhong .
Interpretation of 2024 ACG Clinical Guideline: Focal Liver Lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 656-662.
|
| [8] |
Gong Ge, LI Ang, WANG Xin, LU Yuanyuan .
New advances in diagnosis and treatment of colorectal mucinous adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 663-672.
|
| [9] |
FU Yifan, WANG Boda, HE Yangsong, LU Yuanyuan, WANG Xin .
Advances in tumor biomarkers in liquid biopsy of gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 673-680.
|
| [10] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
| [11] |
JIANG Yuan, WANG Xiaoyan, LEI lei, LIU Lihua, WU Danfeng, ZHANG Siqi, TANG Dairong, FAN Lingli, FENG Gang, XUE Xiaojing.
Summary of the best evidence for blood glucose management in cancer patients with immune checkpoint inhibitors inducing hyperglycemia
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 722-728.
|
| [12] |
HUANG Shihuan, LAN Huiyu, NONG Xiaolian, LI Fanrong, ZHAO Fengjuan, YOU Xuemei.
Network analysis of concurrent symptoms and core symptom identification in patients with intermediate and advanced hepatocellular carcinoma after surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 729-735.
|
| [13] |
WANG Jinming, LI Yaojie, QIU Guogao, LIU Shaoping, LIU Jie, YOU Xuemei, MA Liang, ZHONG Jianhong.
ESMO 2024: new breakthroughs and future trends in hepatocellular carcinoma treatment
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 741-746.
|
| [14] |
WANG Xingchen, LIAO Dawen, LI Jiaying, SUN Xiacheng, BI Qian, Huang Qichao, HUANG Jiangtao.
Comparative analysis of molecular characteristics of constitutive activation of NRAS and CTNNB1 in liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 577-585.
|
| [15] |
DONG Junling, YANG Hui, LI Na.
Trend of the incidence of gastric cancer in China,1992—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 593-597.
|
